Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
Adjuvants, Immunologic
/ pharmacology
Animals
Antigens, Bacterial
/ genetics
Bacterial Proteins
/ genetics
Bacterial Vaccines
/ genetics
Coxiella burnetii
/ immunology
Disease Models, Animal
Guinea Pigs
Humans
Immunogenicity, Vaccine
Q Fever
/ immunology
Recombinant Proteins
/ genetics
Toll-Like Receptors
/ antagonists & inhibitors
Vaccines, Subunit
/ genetics
Vaccines, Synthetic
/ genetics
Coxiella burnetii
TLR agonist
guinea pig model
hypersensitivity
triagonist
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
01
2021
accepted:
01
03
2021
entrez:
5
4
2021
pubmed:
6
4
2021
medline:
28
9
2021
Statut:
epublish
Résumé
Q fever is caused by the obligate intracellular bacterium,
Identifiants
pubmed: 33815413
doi: 10.3389/fimmu.2021.653092
pmc: PMC8010241
doi:
Substances chimiques
Adjuvants, Immunologic
0
Antigens, Bacterial
0
Bacterial Proteins
0
Bacterial Vaccines
0
Recombinant Proteins
0
Toll-Like Receptors
0
Vaccines, Subunit
0
Vaccines, Synthetic
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
653092Informations de copyright
Copyright © 2021 Fratzke, Jan, Felgner, Liang, Nakajima, Jasinskas, Manna, Nihesh, Maiti, Albin, Esser-Kahn, Davies, Samuel, Felgner and Gregory.
Déclaration de conflit d'intérêts
PF, DD, JF, LL, SJ, RN, and AJ own shares in Nanommune Inc. Nanommune does not sell the arrays described in this paper, nor funded any part of the work described herein. Neither Nanommune or its shareholders are likely to benefit from the results described in this publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Infect Immun. 2015 Apr;83(4):1641-9
pubmed: 25667264
Trends Biotechnol. 2019 Apr;37(4):373-388
pubmed: 30470547
Front Immunol. 2020 Jun 19;11:1207
pubmed: 32636840
J Virol. 2017 Sep 12;91(19):
pubmed: 28724768
Bioconjug Chem. 2010 Mar 17;21(3):405-18
pubmed: 19886668
Nat Rev Microbiol. 2013 Aug;11(8):561-73
pubmed: 23797173
PLoS One. 2018 Oct 12;13(10):e0205882
pubmed: 30312355
Infect Immun. 2007 Jul;75(7):3245-55
pubmed: 17438029
Front Microbiol. 2014 Dec 16;5:726
pubmed: 25566235
Comp Med. 2000 Aug;50(4):374-8
pubmed: 11020154
Clin Transl Immunology. 2016 May 20;5(5):e85
pubmed: 27350884
Arch Biochem Biophys. 1972 Feb;148(2):452-65
pubmed: 4623114
Science. 2003 Jun 6;300(5625):1524-5
pubmed: 12791976
J Biol Chem. 2004 Dec 24;279(52):54405-15
pubmed: 15485838
Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents
pubmed: 19366914
Front Immunol. 2020 Jun 11;11:1112
pubmed: 32595636
Proteomics. 2010 Jun;10(12):2259-69
pubmed: 20391532
J Immunol. 2020 Feb 1;204(3):611-621
pubmed: 31871024
Vaccine. 2011 Apr 12;29(17):3341-55
pubmed: 20713100
Bull World Health Organ. 1982;60(3):389-94
pubmed: 6982774
NPJ Vaccines. 2018 Sep 4;3:34
pubmed: 30210819
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):547-52
pubmed: 15647345
J Immunol. 2011 May 15;186(10):5772-83
pubmed: 21498664
Infect Immun. 2010 Jul;78(7):3019-26
pubmed: 20351144
Immune Netw. 2015 Apr;15(2):51-7
pubmed: 25922593
Infect Immun. 2019 Nov 18;87(12):
pubmed: 31501249
Nat Biotechnol. 2015 Nov;33(11):1201-10
pubmed: 26501954
J Immunol. 2010 Mar 1;184(5):2602-10
pubmed: 20124098
Immunity. 2010 May 28;32(5):692-702
pubmed: 20434372
Respirology. 2004 Jun;9(2):278-82
pubmed: 15182283
J Am Chem Soc. 2013 Apr 3;135(13):4962-5
pubmed: 23496091
J Immunol. 2007 Dec 15;179(12):8372-80
pubmed: 18056383
Infect Drug Resist. 2019 Apr 09;12:701-706
pubmed: 31114259
Infect Dis Clin North Am. 2010 Mar;24(1):27-41
pubmed: 20171543
J Cardiol Cases. 2019 Jun 01;20(2):45-48
pubmed: 31440310
Infect Immun. 2013 Jun;81(6):2112-22
pubmed: 23545296
J Med Chem. 2013 Jun 13;56(11):4206-23
pubmed: 23656327
Vaccines (Basel). 2018 Dec 13;6(4):
pubmed: 30551615
Science. 2007 Jun 15;316(5831):1628-32
pubmed: 17569868
J Immunol. 2008 Jan 15;180(2):1080-7
pubmed: 18178848
ACS Cent Sci. 2018 Aug 22;4(8):982-995
pubmed: 30159395
Immunol Res. 2009;43(1-3):138-48
pubmed: 18813881
Nat Rev Immunol. 2011 Jul 25;11(8):519-31
pubmed: 21785456
Sci Rep. 2017 May 31;7(1):2530
pubmed: 28566683
Zoonoses Public Health. 2020 Feb;67(1):79-88
pubmed: 31677254
PLoS One. 2019 Feb 19;14(2):e0211781
pubmed: 30779802
Interdiscip Perspect Infect Dis. 2012;2012:131932
pubmed: 23213331
J Exp Med. 2005 Dec 19;202(12):1715-24
pubmed: 16365150
Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):361-8
pubmed: 23052984
ACS Cent Sci. 2019 Jul 24;5(7):1137-1145
pubmed: 31403067
Infect Immun. 2006 Nov;74(11):6085-91
pubmed: 17057087
Appl Environ Microbiol. 2011 Jun;77(11):3720-5
pubmed: 21478315
Mol Cell Proteomics. 2011 Oct;10(10):M110.006304
pubmed: 21817167
J Immunol. 2014 May 1;192(9):4221-32
pubmed: 24659688
Epidemiol Infect. 1990 Apr;104(2):275-87
pubmed: 2323360